Alabama
Oxford; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
Various Cities; Research Center
Asthma Study CIGE025BUS26
Arizona
Phoenix; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
Arkansas
Jonesboro; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
Little Rock; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
California
Dinuba; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
Fresno; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
Huntington; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
Huntington Beach; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
Long Beach; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
Long Beach; West Coast Clinical Trials
Does your child have asthma?
Long Beach; West Coast Clinical Trials
Does your child have Asthma?
Long Beach; West Coast Clinical Trials
Does your child have Asthma?
Madera; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
Newport Beach; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
Orange; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
Orange; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
Orange; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
Paramount; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
Paramount; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
Paramount; Center for Clinical Trials, LLC
Asthma research can help us learn more
Rolling Hills Estates; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
San Diego; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
San Diego; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
Stockton; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
Torrance; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
Various Cities; Research Center
Asthma Study CIGE025BUS26
Vista; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
Walnut Creek; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
Colorado
Denver; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
Pueblo; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
Pueblo; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
Various Cities; Research Center
Asthma Study CIGE025BUS26
Florida
Altamonte Springs; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
Hialeah; Amedica Research Institute, Inc.
A 12-week, randomized, double blind, active-controlled, multi-center, phase IIIb study comparing the efficacy and evaluating the safety of an investigational medication in adult and adolescent Hispanic subjects with asthma.
Miami; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
Miami; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
Normal; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
Tallahassee; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
Tampa; University of South Florida Asthma, Allergy and Immunology Clinical Research Unit
Does your child suffer from Asthma?
Tampa; University of South Florida Asthma, Allergy and Immunology Clinical Research Unit
Do you or your child suffer from asthma?
Various Cities; Research Center
Asthma Study CIGE025BUS26
Georgia
Carrollton; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
Gainesville; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
Lawrenceville; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
Marietta; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
Savannah; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
Various Cities; Research Center
Asthma Study CIGE025BUS26
Illinois
DeKalb; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
Hoffman Estates; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
Normal; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
Indiana
Various Cities; Research Center
Asthma Study CIGE025BUS26
Kansas
Various Cities; Research Center
Asthma Study CIGE025BUS26
Kentucky
Louisville; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
Louisville; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
Louisville; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
Louisville; Family Allergy and Asthma Research Institute
Adolescent/Adult Asthma Study.
Louisville; Family Allergy and Asthma Research Institute
Pediatric Asthma Study - Ages 5-11.
Various Cities; Research Center
Asthma Study CIGE025BUS26
Louisiana
Kenner; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
Metairie; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
Metairie; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
River Ridge; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
Various Cities; Research Center
Asthma Study CIGE025BUS26
Maryland
Baltimore; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
Glen Burnie; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
Massachusetts
North Dartmouth; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
Various Cities; Research Center
Asthma Study CIGE025BUS26
Michigan
Stevensville; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
Various Cities; Research Center
Asthma Study CIGE025BUS26
Minnesota
Minneapolis; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
Various Cities; Research Center
Asthma Study CIGE025BUS26
Mississippi
Gulfport; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
Missouri
St. Louis; The Clinical Research Center, LLC
Do you have asthma? Do you use your rescue inhaler each week?
St. Louis; The Clinical Research Center, LLC
Do you or does your child have asthma?
Various Cities; Research Center
Asthma Study CIGE025BUS26
Nebraska
Omaha; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
Various Cities; Research Center
Asthma Study CIGE025BUS26
New Jersey
Forked River; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
Skillman; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
Various Cities; Research Center
Asthma Study CIGE025BUS26
New York
Ithaca; Health Sciences Research Center
Pediatric Allergy study for children 6-11 years of age
New City; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
New York; Biomedical Research Alliance of New York
Asthma trial to reduce the need for oral steroids, New York University Medical Center
Olean; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
Poughkeepsie; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
Various Cities; Research Center
Asthma Study CIGE025BUS26
North Carolina
Greenville; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
Greenville; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
Kernersville; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
Raleigh; North Carolina Clinical Research
This study is for individuals with mild to moderate asthma. Qualified participants must be at least 12 years of age.
Raleigh; North Carolina Clinical Research
Attention Parents!
Various Cities; Research Center
Asthma Study CIGE025BUS26
Ohio
Canton; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
Cincinnati; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
Dayton; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
Various Cities; Research Center
Asthma Study CIGE025BUS26
Oklahoma
Oklahoma City; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
Various Cities; Research Center
Asthma Study CIGE025BUS26
Oregon
Gresham; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
Lake Oswego; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
Medford; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
Medford; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
Medford; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
Portland; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
Various Cities; Research Center
Asthma Study CIGE025BUS26
Pennsylvania
Altoona; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
Altoona; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
Erie; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
Philadelphia; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
Pittsburg; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
Pittsburgh; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
Pittsburgh; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
Reading; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
Various Cities; Research Center
Asthma Study CIGE025BUS26
Rhode Island
Various Cities; Research Center
Asthma Study CIGE025BUS26
South Carolina
Charleston; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
Charleston; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
Greenville; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
Orangeburg; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
Tennessee
Chattanooga; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
Dyersburg; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
Knoxville; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
Nashville; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
Various Cities; Research Center
Asthma Study CIGE025BUS26
Texas
Amarillo; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
Dallas; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
Dallas; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
Dallas; Pharmaceutical Research & Consulting, Inc.
Does your child have asthma? (Ages 4-11)
Dallas; Allergy/Immunology Research Center of North Texas
Attention Parents! If your child suffers from asthma, there might be something more you can do.
El Paso; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
Houston; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
Houston; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
Houston; Clinical Trials North Houston
Do you have asthma?
San Antonio; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
San Antonio; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
San Antonio; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
San Antonio; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
Various Cities; Research Center
Asthma Study CIGE025BUS26
Utah
Murray; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
Murray; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
Provo; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
Various Cities; Research Center
Asthma Study CIGE025BUS26
Vermont
Various Cities; Research Center
Asthma Study CIGE025BUS26
Virginia
Burke; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
Charlottesville; University of Virginia
Healthy Kids and Kids with Asthma needed for MRI studies
Charlottesville; University of Virginia
Asthma and Breathlessness in School Age Children
Richmond; Study Site
A study to measure an investigational medication's ability to control asthma versus a marketed product in pediatric subjects whose asthma is worsened by activity or exercise.
Richmond; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
Various Cities; Research Center
Asthma Study CIGE025BUS26
Wisconsin
Burlington; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
Milwaukee; Research Site
A study to assess the efficacy and safety of an investigational drug in children 6-23 months old with symptoms of asthma or reactive airways disease.
Various Cities; Research Center
Asthma Study CIGE025BUS26
